UroGen Pharma (URGN) Tax Provisions (2020 - 2026)
UroGen Pharma (URGN) posted Tax Provisions of -$4.8 million for Q1 2026, down 2580.9% on a QoQ basis from -$178000.0 in Q4 2025, and down 1317.35% year-over-year from $392000.0 in Q1 2025.
UroGen Pharma (URGN) Tax Provisions (2020 - 2026) Analysis & Trends
UroGen Pharma's Tax Provisions history runs 7 years deep, the most recent figure standing at -$4.8 million for Q1 2026.
- Quarterly Tax Provisions fell 1317.35% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.0 million (up 82.3% YoY) and the FY2025 annual result came in at $175000.0, up 100.61% from the prior year.
- Tax Provisions was -$4.8 million for Q1 2026 at UroGen Pharma, down from -$178000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $5.6 million in Q4 2023 and bottomed at -$28.7 million in Q4 2024.
- A 5-year average of -$1.5 million and a median of $54000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2025 — Tax Provisions surged 2571.05% — and 2026, when it tumbled 1317.35%.
- UroGen Pharma's Tax Provisions stood at $689000.0 in 2022, then soared by 718.29% to $5.6 million in 2023, then plunged by 609.28% to -$28.7 million in 2024, then soared by 99.38% to -$178000.0 in 2025, then tumbled by 2580.9% to -$4.8 million in 2026.
- Business Quant data shows URGN's Tax Provisions at -$4.8 million in Q1 2026, -$178000.0 in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn | -4.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.77 Mn |
| Dec 31, 2025 | -178,000.00 |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 392,000.00 |
| Dec 31, 2024 | -28.71 Mn |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | -9,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 689,000.00 |
| Sep 30, 2022 | 709,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | -25.47 Mn |
| Jun 30, 2021 | 312,000.00 |
| Dec 31, 2020 | 3.37 Mn |